ASH presented $150,000 to five investigators through the society’s bridge grant program, designed to sustain promising hematologic research proposals that are not funded through NIH.
“With strict budget caps still in place, the ASH Bridge Grants are more important than ever,” said ASH President Kenneth C. Anderson, MD, director of Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana-Farber Cancer Institute, said in an ASH-issued press release. “This program allows scientific momentum to continue while encouraging the retention of promising hematology researchers, which is especially critical in this era of unpredictable NIH funding.”
The 1-year grants are intended to support researchers who face gaps in multiyear funding.
ASH has presented $11.2 million in bridge grants to 92 investigators since the program’s inception in 2013.
The recipients of the most recent bridge grants are John H. Bushweller, PhD, of University of Virginia; Selina Chen-Kiang, PhD, of Weill Cornell Medicine; Fotini Gounari, PhD, DSc, of The University of Chicago; Akil Merchant, MD, of University of Southern California; and Anupama Narla, MD, of Stanford University.